Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection

Marjan Afrouzian, Vido Ramassar, Joan Urmson, Lin Fu Zhu, Philip F. Halloran

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In many circumstances kidney transplants remain viable despite extensive inflammation, permitting rejection episodes to be reversed. The mechanisms by which the kidney resists host effector mechanisms are not known. In mouse kidney transplants, resistance requires interferon-γ (IFN-γ), which acts on the graft to protect the graft from necrosis during the first days of rejection as well as inducing major histocompatibility complex (MHC) expression. Because some effects of IFN-γ are mediated by transcription factor IRF-1, the role of IRF-1 in the donor tissue early phases of rejection of mouse kidney allografts was studied. H-2b kidneys were transplanted from mice with wild-type IRF-1 genes (WT) or mice with disrupted IRF-1 genes (IRF-1KO) into CBA (H-2k) recipients. At day 5 and day 7, IRF-1KO and WT kidneys were functioning despite typical rejection pathology: interstitial infiltration and tubulitis. However, function deteriorated rapidly in rejecting IRF-1KO allografts, associated with widespread epithelial necrosis, peritubular capillary congestion, glomerulitis, and fibrin thrombi in small veins by day 7. At day 21, WT kidneys were viable despite severe tubulitis and arteritis, whereas IRF-1KO kidneys showed massive necrosis of the epithelium despite patent large vessels. Compared with WT kidneys, rejecting IRF-1KO kidneys showed less induction of donor MHC yet had similar mRNA levels of perforin, granzyme B, and Fas ligand and evoked host alloantibody responses. Thus in rejecting kidney transplants, IRF-1 in the graft mediates MHC induction, but it also mediates resistance to necrosis, an effect that could be crucial to permit success in interventions against rejection.

Original languageEnglish (US)
Pages (from-to)1199-1209
Number of pages11
JournalJournal of the American Society of Nephrology
Volume13
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Interferon Regulatory Factor-1
Necrosis
Transplants
Kidney
Major Histocompatibility Complex
Interferons
Allografts
Isoantibodies
Arteritis
Fas Ligand Protein
Fibrin
Genes
Veins

ASJC Scopus subject areas

  • Nephrology

Cite this

Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection. / Afrouzian, Marjan; Ramassar, Vido; Urmson, Joan; Zhu, Lin Fu; Halloran, Philip F.

In: Journal of the American Society of Nephrology, Vol. 13, No. 5, 2002, p. 1199-1209.

Research output: Contribution to journalArticle

Afrouzian, Marjan ; Ramassar, Vido ; Urmson, Joan ; Zhu, Lin Fu ; Halloran, Philip F. / Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection. In: Journal of the American Society of Nephrology. 2002 ; Vol. 13, No. 5. pp. 1199-1209.
@article{5cf94168c3a6471aa829ea1a82c9b98f,
title = "Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection",
abstract = "In many circumstances kidney transplants remain viable despite extensive inflammation, permitting rejection episodes to be reversed. The mechanisms by which the kidney resists host effector mechanisms are not known. In mouse kidney transplants, resistance requires interferon-γ (IFN-γ), which acts on the graft to protect the graft from necrosis during the first days of rejection as well as inducing major histocompatibility complex (MHC) expression. Because some effects of IFN-γ are mediated by transcription factor IRF-1, the role of IRF-1 in the donor tissue early phases of rejection of mouse kidney allografts was studied. H-2b kidneys were transplanted from mice with wild-type IRF-1 genes (WT) or mice with disrupted IRF-1 genes (IRF-1KO) into CBA (H-2k) recipients. At day 5 and day 7, IRF-1KO and WT kidneys were functioning despite typical rejection pathology: interstitial infiltration and tubulitis. However, function deteriorated rapidly in rejecting IRF-1KO allografts, associated with widespread epithelial necrosis, peritubular capillary congestion, glomerulitis, and fibrin thrombi in small veins by day 7. At day 21, WT kidneys were viable despite severe tubulitis and arteritis, whereas IRF-1KO kidneys showed massive necrosis of the epithelium despite patent large vessels. Compared with WT kidneys, rejecting IRF-1KO kidneys showed less induction of donor MHC yet had similar mRNA levels of perforin, granzyme B, and Fas ligand and evoked host alloantibody responses. Thus in rejecting kidney transplants, IRF-1 in the graft mediates MHC induction, but it also mediates resistance to necrosis, an effect that could be crucial to permit success in interventions against rejection.",
author = "Marjan Afrouzian and Vido Ramassar and Joan Urmson and Zhu, {Lin Fu} and Halloran, {Philip F.}",
year = "2002",
doi = "10.1097/01.ASN.0000013302.11876.A5",
language = "English (US)",
volume = "13",
pages = "1199--1209",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection

AU - Afrouzian, Marjan

AU - Ramassar, Vido

AU - Urmson, Joan

AU - Zhu, Lin Fu

AU - Halloran, Philip F.

PY - 2002

Y1 - 2002

N2 - In many circumstances kidney transplants remain viable despite extensive inflammation, permitting rejection episodes to be reversed. The mechanisms by which the kidney resists host effector mechanisms are not known. In mouse kidney transplants, resistance requires interferon-γ (IFN-γ), which acts on the graft to protect the graft from necrosis during the first days of rejection as well as inducing major histocompatibility complex (MHC) expression. Because some effects of IFN-γ are mediated by transcription factor IRF-1, the role of IRF-1 in the donor tissue early phases of rejection of mouse kidney allografts was studied. H-2b kidneys were transplanted from mice with wild-type IRF-1 genes (WT) or mice with disrupted IRF-1 genes (IRF-1KO) into CBA (H-2k) recipients. At day 5 and day 7, IRF-1KO and WT kidneys were functioning despite typical rejection pathology: interstitial infiltration and tubulitis. However, function deteriorated rapidly in rejecting IRF-1KO allografts, associated with widespread epithelial necrosis, peritubular capillary congestion, glomerulitis, and fibrin thrombi in small veins by day 7. At day 21, WT kidneys were viable despite severe tubulitis and arteritis, whereas IRF-1KO kidneys showed massive necrosis of the epithelium despite patent large vessels. Compared with WT kidneys, rejecting IRF-1KO kidneys showed less induction of donor MHC yet had similar mRNA levels of perforin, granzyme B, and Fas ligand and evoked host alloantibody responses. Thus in rejecting kidney transplants, IRF-1 in the graft mediates MHC induction, but it also mediates resistance to necrosis, an effect that could be crucial to permit success in interventions against rejection.

AB - In many circumstances kidney transplants remain viable despite extensive inflammation, permitting rejection episodes to be reversed. The mechanisms by which the kidney resists host effector mechanisms are not known. In mouse kidney transplants, resistance requires interferon-γ (IFN-γ), which acts on the graft to protect the graft from necrosis during the first days of rejection as well as inducing major histocompatibility complex (MHC) expression. Because some effects of IFN-γ are mediated by transcription factor IRF-1, the role of IRF-1 in the donor tissue early phases of rejection of mouse kidney allografts was studied. H-2b kidneys were transplanted from mice with wild-type IRF-1 genes (WT) or mice with disrupted IRF-1 genes (IRF-1KO) into CBA (H-2k) recipients. At day 5 and day 7, IRF-1KO and WT kidneys were functioning despite typical rejection pathology: interstitial infiltration and tubulitis. However, function deteriorated rapidly in rejecting IRF-1KO allografts, associated with widespread epithelial necrosis, peritubular capillary congestion, glomerulitis, and fibrin thrombi in small veins by day 7. At day 21, WT kidneys were viable despite severe tubulitis and arteritis, whereas IRF-1KO kidneys showed massive necrosis of the epithelium despite patent large vessels. Compared with WT kidneys, rejecting IRF-1KO kidneys showed less induction of donor MHC yet had similar mRNA levels of perforin, granzyme B, and Fas ligand and evoked host alloantibody responses. Thus in rejecting kidney transplants, IRF-1 in the graft mediates MHC induction, but it also mediates resistance to necrosis, an effect that could be crucial to permit success in interventions against rejection.

UR - http://www.scopus.com/inward/record.url?scp=0036238740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036238740&partnerID=8YFLogxK

U2 - 10.1097/01.ASN.0000013302.11876.A5

DO - 10.1097/01.ASN.0000013302.11876.A5

M3 - Article

VL - 13

SP - 1199

EP - 1209

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -